NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US [Yahoo! Finance]
Iron Mountain Incorporated (Delaware)Common Stock REIT (IRM)
Last iron mountain incorporated (delaware)common stock reit earnings: 2/13 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.ironmountain.com/company/for-investors/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Aarhus, Denmark, 22 March 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, today announces that it has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to initiate a Phase 2b clinical trial of NMD670 in patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive. The Phase 2b clinical trial is a dose range-finding, double-blind, placebo-controlled study of NMD670, a twice daily oral muscle-targeted therapy, in gMG patients experiencing persistent symptoms or fluctuating symptoms despite treatment on current standard of care. The trial will take place in both US and European clinical sites. The study is expected to initiate enrollment of patients in the coming months. NMD670 is a first-in-class, muscle-targete
Show less
Read more
Impact Snapshot
Event Time:
IRM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRM alerts
High impacting Iron Mountain Incorporated (Delaware)Common Stock REIT news events
Weekly update
A roundup of the hottest topics
IRM
News
- Here's Why Iron Mountain (IRM) Gained But Lagged the Market Today [Yahoo! Finance]Yahoo! Finance
- Netherlands Colocation Market Report 2024: A US$2.756 Billion Market by 2029, Featuring Iron Mountain, Dataplace, HostDime, NTT, ColoHouse, Equinix, EXA Infrastructure, NorthC and Penta Infra [Yahoo! Finance]Yahoo! Finance
- Iron Mountain (IRM) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
- Is Most-Watched Stock Iron Mountain Incorporated (IRM) Worth Betting on Now? [Yahoo! Finance]Yahoo! Finance
- Iron Mountain Schedules First Quarter 2024 Earnings Release and Conference CallBusiness Wire
IRM
Earnings
- 2/22/24 - Miss
IRM
Sec Filings
- 4/22/24 - Form 4
- 4/22/24 - Form 4
- 4/19/24 - Form DEFA14A
- IRM's page on the SEC website